ReShape Lifesciences Inc. (RSLS) is trading at $1.26, skyrocketing 249.54 percent or $0.89 during Tuesday's trading, with no apparent news driving the movement.
The stock opened at $0.8279 and has traded between $0.72 and $1.42 so far, compared to a previous close of $0.3605 on the Nasdaq. Trading volume has surged to 147 million shares, far exceeding the average of 1.23 million.
Its 52-week range now stands at $0.344 to $29.00.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.